Izeltabart Tapatansine
Product Specifications
Target
Immunology/Inflammation related|||Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related|||Immunology/Inflammation
Purity
0.968
Bioactivity
Izeltabart Tapatansine (IMGC-936) is a CHO-expressing humanized next-generation medetonin-based ADC compound targeting ADAM9-expressing tumors, and exhibits cytotoxicity against ADAM9-positive human tumor cell lines for cancer research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2105836-01 0.1 mL
APC-Linked Monoclonal Antibody to Erythropoietin (EPO)
Sign In for Pricing
View Details 
MBS2105836-02 0.2 mL
APC-Linked Monoclonal Antibody to Erythropoietin (EPO)
Sign In for Pricing
View Details MBS2105836-03 0.5 mL
APC-Linked Monoclonal Antibody to Erythropoietin (EPO)
Sign In for Pricing
View Details 
MBS2105836-04 1 mL
APC-Linked Monoclonal Antibody to Erythropoietin (EPO)
Sign In for Pricing
View Details MBS2105836-05 5 mL
APC-Linked Monoclonal Antibody to Erythropoietin (EPO)
Sign In for Pricing
View Details 
MBS2105836-06 5x 5 mL
APC-Linked Monoclonal Antibody to Erythropoietin (EPO)
Sign In for Pricing
View Details